Monday Lunch Live
23 June 2025 (Video recording below)
Co-designing an EPIC-integrated electronic patient-reported outcome (ePRO) symptom monitoring system for people receiving immune checkpoint inhibitors
In this webinar, Dr Lai-Kwon tackles the challenge of tracking potentially serious side-effects in patients receiving immune checkpoint inhibitors by co-designing an electronic patient-reported outcome (ePRO) system directly within the EPIC electronic medical record. You’ll learn how early involvement of patients, carers, nurses and oncologists in iterative workshops shaped question design, user interfaces and alert workflows—ensuring the tool meets real-world clinical needs while remaining intuitive for end users.
Dr Lai-Kwon demonstrates the seamless technical integration with EPIC’s health-maintenance modules, the setup of real-time symptom alerts, and the embedding of tailored educational resources. The session also covers practical implementation strategies—from pilot testing and stakeholder engagement to measuring success via response rates, alert resolution times and sustained patient engagement. By the end, you’ll have a clear, step-by-step roadmap to launch a scalable, sustainable ePRO symptom-monitoring system in your own EPIC environment.
Chair
Stephanie Chau
Director, EMR Optimisation, Peter MacCallum Cancer Centre
Stephanie started her career as a hospital clinical pharmacist, moving into digital health and electronic prescribing and realising that this was the world for her. Having survived several large public hospitals EMR implementation projects in Victoria, she quickly realised implementing an electronic medical record was only the start of the journey. She believes the optimisation of EMRs, expansion and strategic investment of digital technologies will create opportunities to enable improved patient experience, staff satisfaction, enhanced clinical safety, quality and service delivery.
Speaker
Dr Julia Lai-Kwon
Medical Oncologist, PhD candidate, Peter MacCallum Cancer Centre
Dr Lai-Kwon is an early career medical oncologist and health services researcher at Peter Mac. She has previously trained at the Royal Marsden Hospital, United Kingdom and the Melanoma Institute Australia, Sydney, Australia. Her clinical interests are melanoma and other cutaneous malignancies. Dr Lai-Kwon has research expertise in quality of life research, survivorship and patient-reported outcomes. She has presented nationally and internationally and published on the survivorship experience of people with metastatic cancers receiving immunotherapy and targeted therapy, quality of life issues in people with metastatic melanoma, and the use of patient-reported outcomes in research and routine care.
Resource details
This course is brought to you by
